Maxcare Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-07-2024
- Paid Up Capital ₹ 0.50 M
as on 17-07-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
as on 17-07-2024
- Revenue %
(FY 2022)
- Profit 87.99%
(FY 2022)
- Ebitda 93.62%
(FY 2022)
- Net Worth -3.15%
(FY 2022)
- Total Assets -22.59%
(FY 2022)
About Maxcare Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.50 M.
Rajesh Gupta and Ankita Gupta serve as directors at the Company.
- CIN/LLPIN
U24239MH2006PTC166389
- Company No.
166389
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 2006
- Date of AGM
12 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Maxcare Drugs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Gupta  | Director | 21-Dec-2006 | Current |
| Ankita Gupta | Director | 21-Dec-2006 | Current |
Financial Performance and Corporate Structure Insights of Maxcare Drugs.
Maxcare Drugs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 87.99% increase in profit. The company's net worth dipped by a decrease of 3.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maxcare Drugs?
In 2022, Maxcare Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
27 years 1 month Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 03 May 2012 | ₹2.50 M | Open |
How Many Employees Work at Maxcare Drugs?
Unlock and access historical data on people associated with Maxcare Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Nov 02, 2010, Maxcare Drugs has raised a total of ₹ 0.8 M, with the most recent deal valued at ₹ 0.4 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
